Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Sell
30
HAL Quote, Financials, Valuation and Earnings
Last price:
$26.54
Seasonality move
:
3.75%
Day range:
$25.87 - $26.38
52-week range:
$25.51 - $41.56
Dividend yield:
2.59%
P/E ratio:
9.15x
P/S ratio:
1.01x
P/B ratio:
2.24x
Volume:
7.7M
Avg. volume:
9.6M
1-year change:
-28.23%
Market cap:
$23.1B
Revenue:
$23B
EPS (TTM):
$2.87
Analysts' Opinion
-
Consensus RatingHalliburton has received a consensus rating of Buy. The company's average rating is a Buy based on 16 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $37.20, Halliburton has an estimated upside of 41.65% from its current price of $26.26.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $28.00 representing -6.63% downside risk from its current price of $26.26.
Fair Value
-
According to the consensus of 22 analysts, Halliburton has 41.65% upside to fair value with a price target of $37.20 per share.
HAL vs. S&P 500
-
Over the past 5 trading days, Halliburton has underperformed the S&P 500 by -7.38% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Halliburton does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Halliburton revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Halliburton reported revenues of $5.7B.
Earnings Growth
-
Halliburton earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Halliburton reported earnings per share of $0.65.
Enterprise value:
28.6B
EV / Invested capital:
1.59x
Price / LTM sales:
1.01x
EV / EBIT:
7.45x
EV / Revenue:
1.24x
PEG ratio (5yr expected):
0.97x
EV / Free cash flow:
11.89x
Price / Operating cash flow:
9.71x
Enterprise value / EBITDA:
5.84x
Gross Profit (TTM):
$4.4B
Return On Assets:
10.25%
Net Income Margin (TTM):
11.04%
Return On Equity:
26.15%
Return On Invested Capital:
14.63%
Operating Margin:
17.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $19B | $22.9B | $23.1B | $5.8B | $5.7B | |
| Gross Profit | $2.9B | $4.3B | $4.4B | $1.1B | $1.1B | |
| Operating Income | $2.6B | $4B | $4.2B | $1B | $987M | |
| EBITDA | $3.1B | $4.9B | $4.9B | $1.3B | $1.1B | |
| Diluted EPS | $1.93 | $2.91 | $2.87 | $0.79 | $0.65 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $9B | $9.4B | $10.4B | $11.6B | $12B | |
| Total Assets | $20.9B | $21B | $22.6B | $24.4B | $25.3B | |
| Current Liabilities | $3.9B | $3.9B | $5B | $5.4B | $5.5B | |
| Total Liabilities | $15.7B | $15.3B | $14.9B | $15.3B | $15B | |
| Total Equity | $5.2B | $5.7B | $7.6B | $9.2B | $10.4B | |
| Total Debt | $9.8B | $9.1B | $7.9B | $7.8B | $7.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.8B | $3.2B | $3.8B | $874M | $841M | |
| Cash From Investing | -$804M | -$1.5B | -$1.7B | -$428M | -$436M | |
| Cash From Financing | -$1.5B | -$1.5B | -$1.7B | -$483M | -$347M | |
| Free Cash Flow | $784M | $1.9B | $2.4B | $465M | $502M | |
HAL
Sector
Market Cap
$23.1B
$65.3M
Price % of 52-Week High
63.19%
61.28%
Dividend Yield
2.59%
0%
Shareholder Yield
5.73%
5.21%
1-Year Price Total Return
-28.23%
-21.05%
Beta (5-Year)
1.903
1.065
Dividend yield:
2.59%
Annualized payout:
$0.64
Payout ratio:
23.36%
Growth streak:
2 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$27.10
200-day SMA
Sell
Level
$33.09
Bollinger Bands (100)
Sell
Level
28.18 - 31.32
Chaikin Money Flow
Buy
Level
783.4M
20-day SMA
Sell
Level
$29.22
Relative Strength Index (RSI14)
Sell
Level
28.22
ADX Line
Sell
Level
17.67
Williams %R
Buy
Level
-87.7351
50-day SMA
Sell
Level
$29.27
MACD (12, 26)
Sell
Level
-1.07
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
327.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.7235)
Buy
CA Score
(Annual)
Level (0.0182)
Buy
Beneish M-Score
(Annual)
Level (-2.7359)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.223)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Halliburton is North America’s largest oilfield service company as measured by market share. Despite industry fragmentation, it holds a leading position in the hydraulic fracturing and completions market, which makes up nearly half of its revenue. It also holds strong positions in other service offerings like drilling and completions fluids, which leverages its expertise in material science, as well as the directional drilling market. While we consider SLB the global leader in reservoir evaluation, we think Halliburton leads in any activity from the reservoir to the wellbore. The firm’s innovations have helped multiple producers lower their development costs per barrel of oil equivalent, with techniques that have been homed in over a century of operations.
Stock Forecast FAQ
In the current month, HAL has received 16 Buy ratings 6 Hold ratings, and 0 Sell ratings. The HAL average analyst price target in the past 3 months is $37.20.
-
Where Will Halliburton Stock Be In 1 Year?
According to analysts, the consensus estimate is that Halliburton share price will rise to $37.20 per share over the next 12 months.
-
What Do Analysts Say About Halliburton?
Analysts are divided on their view about Halliburton share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Halliburton is a Sell and believe this share price will drop from its current level to $28.00.
-
What Is Halliburton's Price Target?
The price target for Halliburton over the next 1-year time period is forecast to be $37.20 according to 22 Wall Street analysts, 16 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is HAL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Halliburton is a Buy. 16 of 22 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HAL?
You can purchase shares of Halliburton via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Halliburton shares.
-
What Is The Halliburton Share Price Today?
Halliburton was last trading at $26.54 per share. This represents the most recent stock quote for Halliburton. Yesterday, Halliburton closed at $26.26 per share.
-
How To Buy Halliburton Stock Online?
In order to purchase Halliburton stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 6.85% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is up 0.85% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.55% over the past day.
